Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Sitagliptin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sitagliptin 100mg tablets
0601023X0AAAAAA
|
Sitagliptin | Sitagliptin | Endocrine System | 430,598 |
|
Sitagliptin 50mg tablets
0601023X0AAABAB
|
Sitagliptin | Sitagliptin | Endocrine System | 87,621 |
|
Sitagliptin 25mg tablets
0601023X0AAACAC
|
Sitagliptin | Sitagliptin | Endocrine System | 41,668 |
|
Sitagliptin 100mg/5ml oral solution sugar free
0601023X0AAAFAF
|
Sitagliptin | Sitagliptin | Endocrine System | 326 |
|
Sitagliptin 125mg/5ml oral solution sugar free
0601023X0AAAGAG
|
Sitagliptin | Sitagliptin | Endocrine System | 13 |
|
Sitagliptin 50mg/5ml oral solution
0601023X0AAADAD
|
Sitagliptin | Sitagliptin | Endocrine System | No data available |
|
Sitagliptin 50mg/5ml oral suspension
0601023X0AAAEAE
|
Sitagliptin | Sitagliptin | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.